Global marketing and registration of finished dosage forms
Breathing life into markets
We are your perfect partner for an early and global market entry!
We at Tiefenbacher strongly believe that our high-quality medicines should be available and affordable for all patients – irrespective of their origin or income level. That´s why we always strive for a global and early market entry for our customers. Thanks to our high excellence and international knowledge in research & development and regulatory affairs, we have already obtained more than 15.000 marketing authorizations in over 80 markets worldwide.
While we master the complexity of country-specific regulatory requirements and maintain close contact to the relevant pharmaceutical authorities, our customers can focus on their important brand marketing and save time and money. Outstanding intellectual property guidance, a professional project management, and an efficient supply chain approach are further important drivers for our strong track record in generating first-to-file-dossiers.

Our global licensing approach
Global availability of our high-quality developments: marketing authorizations in 80+ countries

15.000+
marketing authorizations worldwide
15.000+
marketing authorizations worldwide
Tiefenbacher market access at a glance
Our strong track record in marketing and registration speaks for us
15.000+
MAs obtained
in80+
countries worldwide
150+
marketing partners on five continents
350+
tender awards in 12 months
15.000+
MAs obtained
in80+
countries worldwide
150+
marketing partners on five continents
350+
tender awards in 12 months
highly rated regulatory expertise
frequent first-to-file generic dossiers
first NCE approved
several US filings
highly rated regulatory expertise
frequent first-to-file generic dossiers
first NCE approved
several US filings

Dr. Kristian Ruepp
Managing Director
„Thanks to our international knowledge in R&D and regulatory affairs, we enable our customers to enter global markets as fast as possible – making our high-quality medicines more affordable and more available for patients worldwide."
We are happy to help, get in touch
Thanks to our extensive experience and profound expertise in the international pharmaceutical markets, we can help you achieve sustainable and profitable growth with our advanced medicines. Contact us.

Find out more on aet.eu